Sana Biotechnology SANA Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by Sana Biotechnology in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The official record: Sana Biotechnology’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sana Biotechnology's total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Sana Biotechnology's total equity?
- Sana Biotechnology (SANA) reported total equity of $119.24M in Q1 2026.
- How has Sana Biotechnology's total equity changed year-over-year?
- Sana Biotechnology's total equity decreased by 43.0% year-over-year, from $209.08M to $119.24M.
- What is the long-term trend for Sana Biotechnology's total equity?
- Over 5 years (2020 to 2025), Sana Biotechnology's total equity has grown at a -17.5% compound annual growth rate (CAGR), from -$421.18M to $160.88M.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.